159 related articles for article (PubMed ID: 26670723)
21. Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.
Agarwal AK; Singh M; Arya V; Garg U; Singh VP; Jain V
J Assoc Physicians India; 2012 Jul; 60():28-32. PubMed ID: 23405538
[TBL] [Abstract][Full Text] [Related]
22. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
[TBL] [Abstract][Full Text] [Related]
23. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
24. Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis.
Reid CM; Ademi Z; Nelson MR; Connor G; Chew DP; Shiel L; Smeath A; De Looze F; Steg PG; Bhatt DL; Liew D;
Med J Aust; 2012 Feb; 196(3):193-7. PubMed ID: 22339526
[TBL] [Abstract][Full Text] [Related]
25. History of peripheral artery disease and cardiovascular risk of real-world patients with acute coronary syndrome: Role of inflammation and comorbidities.
Denegri A; Magnani G; Kraler S; Bruno F; Klingenberg R; Mach F; Gencer B; Räber L; Rodondi N; Rossi VA; Matter CM; Nanchen D; Obeid S; Lüscher TF
Int J Cardiol; 2023 Jul; 382():76-82. PubMed ID: 36958395
[TBL] [Abstract][Full Text] [Related]
26. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.
Inglis SC; Bebchuk J; Al-Suhaim SA; Case J; Pfeffer MA; Solomon SD; Hou YR; Pitt B; Dargie HJ; Ford I; Kjekshus J; Zannad F; Dickstein K; McMurray JJ
Int J Cardiol; 2013 Sep; 168(2):1094-101. PubMed ID: 23194780
[TBL] [Abstract][Full Text] [Related]
27. Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy.
Capodanno D; Rossini R; Musumeci G; Lettieri C; Senni M; Valsecchi O; Angiolillo DJ; Lip GY
Int J Cardiol; 2015 Nov; 199():319-25. PubMed ID: 26241637
[TBL] [Abstract][Full Text] [Related]
28. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.
Berger JS; Krantz MJ; Kittelson JM; Hiatt WR
JAMA; 2009 May; 301(18):1909-19. PubMed ID: 19436018
[TBL] [Abstract][Full Text] [Related]
29. Is aspirin still the drug of choice for management of patients with peripheral arterial disease?
Poredos P; Jezovnik MK
Vasa; 2013 Mar; 42(2):88-95. PubMed ID: 23485835
[TBL] [Abstract][Full Text] [Related]
30. Comparison of antiplatelet efficacy and tolerability of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients after percutaneous coronary intervention: a prospective, multicenter, randomized, open-label, phase IV, noninferiority trial.
Park JB; Koo BK; Choi WG; Kim SY; Park J; Kwan J; Park CG; Kim HS
Clin Ther; 2013 Jan; 35(1):28-37.e4. PubMed ID: 23328268
[TBL] [Abstract][Full Text] [Related]
31. Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006-2015.
Sundaram V; Bloom C; Zakeri R; Halcox J; Cohen A; Bowrin K; Briere JB; Banerjee A; Simon DI; Cleland JGF; Rajagopalan S; Quint JK
Eur Heart J; 2020 May; 41(17):1636-1649. PubMed ID: 31883328
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and clinical implications of newly revealed, asymptomatic abnormal ankle-brachial index in patients with significant coronary artery disease.
Lee JY; Lee SW; Lee WS; Han S; Park YK; Kwon CH; Jang JY; Cho YR; Park GM; Ahn JM; Kim WJ; Park DW; Kang SJ; Kim YH; Lee CW; Park SW; Park SJ
JACC Cardiovasc Interv; 2013 Dec; 6(12):1303-13. PubMed ID: 24355120
[TBL] [Abstract][Full Text] [Related]
33. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
; Anand S; Yusuf S; Xie C; Pogue J; Eikelboom J; Budaj A; Sussex B; Liu L; Guzman R; Cina C; Crowell R; Keltai M; Gosselin G
N Engl J Med; 2007 Jul; 357(3):217-27. PubMed ID: 17634457
[TBL] [Abstract][Full Text] [Related]
34. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women.
Wessel TR; Arant CB; Olson MB; Johnson BD; Reis SE; Sharaf BL; Shaw LJ; Handberg E; Sopko G; Kelsey SF; Pepine CJ; Merz NB
JAMA; 2004 Sep; 292(10):1179-87. PubMed ID: 15353530
[TBL] [Abstract][Full Text] [Related]
35. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
Høgh AL
Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
[TBL] [Abstract][Full Text] [Related]
36. Use of Thromboelastography with Platelet Mapping to Identify Prothrombotic Coagulation Profiles in Patients with History of Cardiac Intervention Undergoing Lower Extremity Revascularization.
Hall R; Majumdar M; Cassidy R; Feldman Z; Suarez S; Goudot G; Bellomo T; Jessula S; Kirshkaln A; Dua A
J Am Coll Surg; 2023 Mar; 236(3):495-504. PubMed ID: 36729802
[TBL] [Abstract][Full Text] [Related]
37. Updates in antiplatelet agents used in cardiovascular diseases.
Cheng JW
J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):514-24. PubMed ID: 24213473
[TBL] [Abstract][Full Text] [Related]
38. Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?
Sigvant B; Henriksson M; Lundin F; Wahlberg E
Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):254-61. PubMed ID: 21450673
[TBL] [Abstract][Full Text] [Related]
39. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.
Bhatt DL; Peterson ED; Harrington RA; Ou FS; Cannon CP; Gibson CM; Kleiman NS; Brindis RG; Peacock WF; Brener SJ; Menon V; Smith SC; Pollack CV; Gibler WB; Ohman EM; Roe MT;
Eur Heart J; 2009 May; 30(10):1195-202. PubMed ID: 19339264
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of antiplatelet therapy in atherosclerotic disease: comparing the ASA low-response prevalence in CVD, CAD and PAD.
Meves SH; Hummel T; Endres HG; Mayböck N; Kaiser AF; Schröder KD; Rüdiger K; Overbeck U; Mumme A; Mügge A; Neubauer H
J Thromb Thrombolysis; 2014; 37(2):190-201. PubMed ID: 23553246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
